Opioid Reduced Anesthesia With Parasternal CATheters on Postoperative Delirium After Cardiac Surgery
ORACAT
1 other identifier
observational
100
1 country
1
Brief Summary
PostOperative Delirium (POD) is the most common neuropsychiatric complication following cardiac surgery and may be related to morphine consumption. PostOperative Delirium (POD) prolongs hospital and intensive care unit (ICU) length of stay (LOS) and increases morbidity and mortality. No study has been conducted to demonstrate the effect of regional anesthesia using catheters inserted before sternotomy.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started May 2022
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 2, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
August 1, 2022
CompletedFirst Submitted
Initial submission to the registry
May 19, 2023
CompletedFirst Posted
Study publicly available on registry
May 30, 2023
CompletedJune 15, 2023
June 1, 2023
3 months
May 19, 2023
June 13, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Number of Postoperative delirium (POD) assessed using the Confusion Assessment Method for the Intensive Care Unit (CAM-ICU) in the first 48 hours after surgery
assessed using the Confusion Assessment Method for the Intensive Care Unit (CAM-ICU). Delirium is diagnosed when criteria 1 and 2 are positive, as well as criteria 3 or 4.
Hours: 48
Secondary Outcomes (7)
Number of hypoxemia postoperative in the first 48 hours after extubation
Hours: 48
Number of Ileus postoperative in the first 48 hours after extubation
Hours: 48
Total morphine consumption within 48h after extubation
Hours: 48
Pain at 24 hours and 48 hours postoperative
Hours: 24, 48
postoperative nausea and vomiting
Hours: 48
- +2 more secondary outcomes
Study Arms (2)
opioid reduced anesthesia with parasternal catheters inserted before sternotomy
Patients with opioid reduced anesthesia with parasternal catheters inserted before sternotomy will be included.
Opioid Anesthesia (OA)
Patients with Opioid Anesthesia (OA) will be included.
Interventions
collection of datas: * Post-operative occurrence (within the first 48 hours after extubation) of post-operative delirium via the CAM-ICU (Confusion Assessment Method for the Intensive Care Unit) scale result * Post-operative hypoxemia defined as a PaO2/FiO2 ratio \< 300 in the first 48 hours after extubation * reflex ileus defined as the absence of gas and/or matter in the first 48 hours after extubation, * total morphine consumption in the first 48 hours after surgery * pain at 24 hours and 48 hours after surgery * post-operative nausea and vomiting, major complications (neurological, respiratory, cardiac, infectious) * mortality 30 days after surgery
Eligibility Criteria
Patients with Scheduled Cardiac Surgery for Coronary Artery Bypass Grafting or Valvular Sternotomy in Patients Aged 18 to 85 Years will be included.
You may qualify if:
- Age over 18
- Admitte for scheduled cardiac surgery with sternotomy under cardiopulmonary bypass (CPB) for coronary artery bypass grafting (CABG), surgical correction of valve disease (aortic, mitral or tricuspid) or combined surgery (coronary artery bypass grafting (CABG) and valve replacement).
You may not qualify if:
- Age over 85,
- emergency surgery or heart transplant,
- body mass index (BMI) more than 40 kg.m-2
- reoperation
- Renal insufficiency with glomerular filtration rate (GFR) less than 30 mL.min-1
- left ventricular ejection fraction less than 30%
- respiratory insufficiency with arterial pressure of oxygen less than 60 mmHg
- hepatic insufficiency with prothrombin rate less than 30% or cirrhosis
- chronic hyperglycemia not controlled
- pregnancy
- cognitive impairment chronic use of opioids or drug addiction
- epilepsy
- guardianship
- allergy to locals anesthesics or any drugs
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
CHU Saint-Etienne
Saint-Etienne, France
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Nathalie GRAND, MD
CHU SAINT-ETIENNE
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 19, 2023
First Posted
May 30, 2023
Study Start
May 2, 2022
Primary Completion
August 1, 2022
Study Completion
August 1, 2022
Last Updated
June 15, 2023
Record last verified: 2023-06
Data Sharing
- IPD Sharing
- Will not share